Mutant Tbl1x male mice have a short lifespan and do not breed: unexpected findings

Yalan Hu,Gemma F Codner,Michelle Stewart,Susanne E La Fleur,Paul As van Trotsenburg,Eric Fliers,Raoul C Hennekam,Anita Boelen
DOI: https://doi.org/10.1530/jme-23-0116
2024-02-22
Journal of Molecular Endocrinology
Abstract:Humans with the mutation Y509C in transducin beta like 1 X-linked (TBL1X HGNC ID HGNC:11585) have been reported to present with the combination of central congenital hypothyroidism and impaired hearing. TBL1X belongs to the WD40 repeat-containing protein family, is part of NCoR and SMRT corepressor complexes, and thereby involved in thyroid hormone signaling. In order to investigate the effects of the Y509C mutation in TBL1X on cellular thyroid hormone action, we aimed to generate a hemizygous male mouse cohort carrying the Tbl1x Y459C mutation which is equivalent to the human TBL1X Y509C mutation using CRISPR/Cas9 technology. Hemizygous male mice were small at birth and inactive. Their life span (median lifespan 93 days) was very short compared with heterozygote female mice (survived to >200 days with no welfare issues). 52% of mice did not survive to weaning (133 mice). Of the remaining 118 mice, only 8 were hemizygous males who were unable to mate whereby it was impossible to generate homozygous female mice. In conclusion, the Tbl1x Y459C mutation in male mice has a marked negative effect on birth weight, survival and fertility of male mice. The present findings are unexpected as they are in contrast to the mild phenotype in human males carrying the equivalent TBL1X Y509C mutation.
endocrinology & metabolism
What problem does this paper attempt to address?